Moleculer study of acenitobacter bumannii associated with corona virus disease

https://doi.org/10.53730/ijhs.v6nS1.5296

Authors

  • Noor Qahtan AL Sarraf Al-Qadisiyah University / College of Education / Department of Life Sciences
  • Dina Mohammed Raouf Al-Qadisiyah University / College of Education / Department of Life Sciences

Keywords:

Moleculer Study, Corona Virus Disease, Acenitobacter bumannii

Abstract

In this current study, 120 samples were taken from Corona virus patients of different ages and of both sexes (males and females), who are in isolation units for Corona virus disease in hospitals in Muthanna Governorate during the period from (September to April) and were cultivated in the Chrom agar Base Acinetobacter. After determine the phenotypic and external characteristics, and conduct chemical tests, Then it was diagnosed by 16S-23S ribosomal DNA intergenic spacer region after conducting chemical and molecular tests , 24 out of 120 isolates were confirmed as  Acenitobacter bumannii  , Where 10 positive samples were selected for testing 16S-23S ribosomal DNA intergenic spacer region It  was diagnosed as Acenitobacter bumannii. The gene was diagnosed PonA gene responsible for the enzyme penicillin-binding protein 1a, The gene responsible for the enzyme Beta-Lactamases PER-1 is the BlaPER1 gene, As the most important virulence factors in Acenitobacter bumannii , Because the two enzymes played an important role in the pathogenesis of these bacteria . And the result was (100% of the PonA gene and 40% of the blaPER1  gene).

Downloads

Download data is not yet available.

References

Al-Romaihi, H.E.; Smatti, M.K.; Ganesan, N.; Nadeem, S.; Farag, E.; Coyle, P.V.; Nader, J.D.; Al-Khatib, H.A.; Elmagboul, E.B.; Al Dhahry, S.; et al.( 2019) Epidemiology of respiratory infections among adults in Qatar (2012-2017). PLoS ONE, 14, e0218097

Badr Eldeen, N. A. (2021). Detection of blaOXA-58-like and blaOXA-23-like Genes among Carbapenem Resistant Acinetobacter baumanii strains in Benha University Hospital. Egyptian Journal of Medical Microbiology, 30(4), 33-38.

CDC.Eberhardt ,M.S.; Ingram, D.D.; Makuc, D.M. et al. ( 2001) Urban and Rural Health Chartbook. Health, United States. Hyattsville, Maryland: National Center for Health Statistics.

Ciotti, M., Maurici, M., Santoro, V., Coppola, L., Sarmati, L., De Carolis, G., ... & Pica, F. (2020). Viruses of respiratory tract: an observational retrospective study on hospitalized patients in Rome, Italy. Microorganisms, 8(4), 501

Clancy, C. J., & Nguyen, M. H. (2020). Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect?. Clinical Infectious Diseases, 71(10), 2736-2743.

Contreras-Martel, C., Job, V., Di Guilmi, A. M., Vernet, T., Dideberg, O., & Dessen, A. (2006). Crystal structure of penicillin-binding protein 1a (PBP1a) reveals a mutational hotspot implicated in β-lactam resistance in Streptococcus pneumoniae. Journal of molecular biology, 355(4), 684-696

Dijkshoorn, L., Nemec, A., and Seifert, H. (2007). An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol., 5:939-951.

Feldman, C., & Anderson, R. (2021). The role of co-infections and secondary infections in patients with COVID-19. Pneumonia, 13(1), 1-15.

‏Ghafourian, S.; Sadeghifard, N.; Soheili, S.; Sekawi, Z. .( 2015) Extended spectrum beta-lactamases: Definition, classification and epidemiology. Curr. Issues Mol. Biol., 17, 11–22.

Kempf, M. and Rolain, J. M. (2012) 'Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options', Int J Antimicrob Agents, 39(2), 105-14.

Koenigs, A., Stahl, J., Averhoff, B., Göttig, S., Wichelhaus, T. A., Wallich, R., ... & Kraiczy, P. (2016). CipA of Acinetobacter baumannii is a novel plasminogen binding and complement inhibitory protein. The Journal of infectious diseases, 213(9), 1388-1399.

Lovrić, R., Farčić, N., Mikšić, Š., & Včev, A. (2020). Studying during the COVID-19 pandemic: A qualitative inductive content analysis of nursing students’ perceptions and experiences. Education Sciences, 10(7), 188.

Mueller, A. L., McNamara, M. S., & Sinclair, D. A. (2020) . Why does COVID-19 disproportionately affect older people?. Aging (Albany NY), 12(10), 9959.

Munoz-Price, L. S.; Zembower, T.; Penugonda, S.; Schreckenberger, P.; Lavin, M. A.; Welbel, S.; Vais, D.; Baig, M.; Mohapatra, S.; Quinn, J. P. and Weinstein, R. A. (2010). Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections: Study of a 2-State Monoclonal Outbreak. Infect. Control Hosp. Epidemiol. 31(10):18-27.

‏Priyadharsini, J. V., Girija, A. S., & Paramasivam, A. (2018). In silico analysis of virulence genes in an emerging dental pathogen A. baumannii and related species. Archives of oral biology, 94, 93-98.‏

Shea, O. MK. (2012). Acinetobacter in modern warfare. Int J Antimicrob Agents. May;, 39(5), 363-75.

Tooke, C.L.; Hinchliffe, P.; Bragginton, E.C.; Colenso, C.K.; Hirvonen, V.H.A.; Takebayashi, Y.; Spencer, J .( 2019) β-Lactamases and β-Lactamase Inhibitors in the 21st Century. J. Mol. Biol. 431, 3472–3500

Yang, H.; Liang, L.; Lin, S. and Jia, S. (2010).Isolationland Characterization of a Virulent Bacteriophage AB1 of Acinetobacter baumannii .BMC Microbiol. 10: 131-141

Published

02-04-2022

How to Cite

AL Sarraf, N. Q., & Raouf, D. M. (2022). Moleculer study of acenitobacter bumannii associated with corona virus disease. International Journal of Health Sciences, 6(S1), 3065–3074. https://doi.org/10.53730/ijhs.v6nS1.5296

Issue

Section

Peer Review Articles